Short answer
TuHURA Biosciences, Inc./NV (HURA) filed an 8-K current report with the SEC on November 6, 2026 reporting Item 2.03 (Creation of a Direct Financial Obligation). Additional $1.5 million revolving-credit draw received November 2, 2026.
TuHURA Biosciences, Inc./NV 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.03 · Creation of a Direct Financial Obligation
- Additional $1.5 million revolving-credit draw received November 2, 2026
- Proceeds intended for general corporate purposes, supporting near-term liquidity
- Facility maximum availability $50 million, maturing April 21, 2031
- Borrowing increases debt obligations, with interest and repayment terms governed by the Loan Agreement
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other TuHURA Biosciences, Inc./NV 8-K filings
Get the next HURA 8-K as it lands
Follow HURA for push alerts, or ask the research agent what this filing means.